FDA Inspection 588676 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 3006468609

The FDA completed an inspection of Octapharma Plasma, Inc. on May 29, 2009 in Wichita, KS. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 5 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
May 29, 2009
Fiscal Year
2009
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Wichita, KS (United States)

Citations

IDCFRDescription
15521 CFR 606.160(b)Required records
324821 CFR 640.63(a)Determining donor suitability
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
904421 CFR 600.10(b)Personnel capabilities
931721 CFR 640.65(b)(8)Timing